RemSleep Holdings (RMSL) Cash from Investing Activities Growth (1y) (2015 - 2024)
RemSleep Holdings (RMSL) Cash from Investing Activities Growth (1y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -4,224.26% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 95.53% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 3.20% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -18.20% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -208.79% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -514.25% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -187.82% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -397.90% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -211.17% |
| 10 | RemSleep Holdings | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -336.91% |
| Dec 31, 2023 | 77.02% |
| Mar 31, 2023 | -415.76% |
| Dec 31, 2022 | -76.34% |
| Jun 30, 2022 | -68,366.18% |
| Mar 31, 2022 | -40.67% |
| Dec 31, 2021 | -12,703.56% |
| Sep 30, 2021 | -143.62% |
| Jun 30, 2021 | 99.67% |
| Mar 31, 2021 | -136.07% |
| Dec 31, 2020 | 99.47% |
| Sep 30, 2020 | 69.04% |
| Jun 30, 2020 | -741.20% |
| Mar 31, 2020 | 69.38% |
| Dec 31, 2019 | -150.80% |
| Sep 30, 2019 | -44.88% |
| Jun 30, 2019 | 63.34% |
| Sep 30, 2018 | -730.50% |
| Jun 30, 2018 | -121.60% |
| Sep 30, 2017 | 200.00% |